Topoisomerase II inhibitor 20 (TFA)
Selected Variant
HY-158061A
Size: 5 mg
Topoisomerase II inhibitor 20 TFA is a potent topoisomerase II inhibitor with IC50 of 0.98 µM. Topoisomerase II inhibitor 20 TFA can induce apoptosis and has broad-spectrum anticancer activity[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Topoisomerase
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/topoisomerase-ii-inhibitor-20-tfa.html
Purity
96.82
Smiles
O=C(C1=CN(CC)C2=C(C=C(F)C(N3CC(C)NCC3)=C2F)C1=O)N/N=C/C4=CC=CS4.OC(C(F)(F)F)=O
Molecular Formula
C24H24F5N5O4S
Molecular Weight
573.54
References & Citations
[1]Adly ME, et al. Design, synthesis and in vitro anticancer activity of some new lomefloxacin derivatives. Sci Rep. 2024 Mar 14;14 (1) :6175
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Topo II
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-Kallistatin/SERPINA4 Antibody Picoband®, HRP Conjugate
HPV-16 (Human Papilloma Virus 16) (rHPV16L1/1058), CF594 conjugate, 0.1mg/mL
Rb1 (Tumor Suppressor Protein) (RB1/2313R), CF740 conjugate, 0.1mg/mL
Anti-RGL4 Antibody Picoband®, HRP Conjugate
